Surgically Treated Displaced Mid-diaphyseal Clavicle Fractures
Launched by UNIVERSITY OF CALGARY · May 19, 2023
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the outcomes of surgical treatment for patients with a specific type of broken collarbone called a displaced mid-diaphyseal clavicle fracture. The goal is to understand how well patients recover after surgery, including both physical healing seen on X-rays and how they feel about their recovery. The trial will also compare different surgical techniques to see which one has fewer cases where patients need to have the surgical hardware removed in the two years following the procedure.
To participate in this trial, individuals need to be 18 years or older and have received surgical treatment for their clavicle fracture within 21 days of the injury. It's important that participants can give their consent and are able to follow up on their progress. However, some people may not qualify, such as those with certain types of bone injuries, existing health issues, or those who cannot participate in follow-up visits. If eligible, participants can expect to be closely monitored for their recovery and will contribute valuable information that may help improve treatment for future patients with similar injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Treated with surgical fixation for a displace mid-diaphyseal clavicle fracture.
- • Aged 18 years of age or older and skeletally mature.
- • Enrolled within 21 (+3 days) of injury.
- • Willing and able to complete consent and study participation.
- Exclusion Criteria:
- • Pathological fractures.
- • Clavicle non-unions.
- • Current or prior ipsilateral upper extremity injury that may impact functional outcomes.
- • Polytrauma patients with injuries projected to affect rehabilitation course.
- • Active malignancy.
- • Inability to provide consent or complete follow-up.
- • Incarcerated patients.
About University Of Calgary
The University of Calgary is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university's clinical research initiatives aim to address pressing health challenges and improve patient outcomes. The institution fosters a robust environment for academic inquiry, leveraging state-of-the-art facilities and a diverse network of experts in various fields. Committed to ethical research practices and community engagement, the University of Calgary strives to translate scientific discoveries into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Calgary, Alberta, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported